Boehringer and Geneart collaborate on DNA-based pharmaceuticals
The collaboration includes a transfer of Boehringer Ingelheim technology to Geneart for the production and purification of plasmid DNA. The two partner companies also plan to closely collaborate
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.